Neuravi is a medical device company developing a thrombectomy device to help in the effective medical management of strokes. Neuravi’s device will assist medics to treat their patients expediently after stroke onset by removing the offending clots with its proprietary 3D Stent Trap technology. The WDC was a seed investor in the company which recently completed a Series A round with Fountain Healthcare Partners and Delta Partners. Neuravi expects to grow to 25 new highly skilled jobs. Established in 2009, Neuravi has assembled a large body of intellectual property in the field of mechanical retrieval devices for stroke and has positioned itself to be a major strategic player in this fast developing market. There are an estimated 700,000 ischemic strokes in the US and a further 950,000 in Europe each year.